The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Masitinib......hopefully you'll hear more about this

coloCan
coloCan CSN Member Posts: 1,944 Member

For now,if you go to globenewswire.com and type "Masitinib" into " search" you'll be looking for "AB Science Reports Positive Clinical Study Data" from a phase II trial and now gearing up for phaseIII as a second-line TX for mCRC......

 

Comments

  • coloCan
    coloCan CSN Member Posts: 1,944 Member
    Also,expect to hear more about TAS 102

    as well as Cyramza(ramucirumab) in the near future......and maybe pictilisib

     

  • coloCan
    coloCan CSN Member Posts: 1,944 Member
    coloCan said:

    Also,expect to hear more about TAS 102

    as well as Cyramza(ramucirumab) in the near future......and maybe pictilisib

     

    and getting good reports on a phase II trial is something

    called NPC-1C.....while BIBF-1120 is still in play

    And for those in need for something new for chemo-induced nausea and vomiting, the FDA recently approved something called Akynzeo......

    (Vit D getting major coverage in media today as contributor to CRC survival)